It’s only fair to share… Dipivefrine Molecular FormulaC19H29NO5 Average mass351.437 Da 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate) 52365-63-6 [RN] (±)-3,4-Dihydroxy-a-[(methylamino)methyl]benzyl Alcohol 3,4-Dipivalate 1-(3′,4′-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol 2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester дипивефрин [Russian] [INN] ديبيفيفرين [Arabic] [INN] 地匹福林 [Chinese] [INN] ジピベフリン 4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate D Epifrin [Trade name] Diopine [Trade name] MFCD00673243 [MDL number] Pivalephrine [Trade name] Pro-Epinephrine Propine [Trade name] Thilodrin [Trade name] ATC:S01EA02 Use:antiglaucoma Dipivefrine hydrochloride CAS 64019-93-8 Formula:C19H29NO5 • HCl MW:387.90 g/mol Dipivefrine (INN) or dipivefrin (USAN), trade name Propine among …
Etosalamide, этосаламид , إيتوسالاميد , 依托柳胺 ,
It’s only fair to share… Etosalamide ethosalamide Cas 15302-15-5 Chemical Formula: C11H15NO3 Molecular Weight: 209.245 o-(2-Ethoxyethoxy)benzamide 1585 1PU994YJUH этосаламид [Russian] [INN] إيتوسالاميد [Arabic] [INN] 依托柳胺 [Chinese] [INN] 2-(2-ethoxyethoxy)benzamide UNII-1PU994YJUH 1PU994YJUH HY-B1015 ZINC3623372 AKOS030526102 CCG-213900 CS-4528 AB01563362_01 SR-01000944263 SR-01000944263-1 Etosalamide, also known as Ethosalamide, is an antipyretic and analgesics agent SYN OR CAS:592-55-2, 2-Bromoethyl ethyl ether Cas, 611-20-1, 2-Hydroxybenzonitrile PATENT DE 1013643 PATENT GB 774635 PATENT US2822391 78 …
GUEST POST, POOJA KUMAR, CURRENT SCENARIO OF PATENTS IN INDIA
It’s only fair to share… CURRENT SCENARIO OF PATENTS IN INDIA By Ms. Pooja Kumar (Registered Patent agent/Director of Innove Intellects) Email id: pooja@innoveintellects.com Patent is a monopoly, exclusive rights given to an individual or a company or an organization to make, sell, use and import an invention for a limited period of years. In …
FDA approves first treatment Ruzurgi (amifampridine) for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
It’s only fair to share… FDA approves first treatment Ruzurgi (amifampridine) for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age. This is the first FDA …
Beperminogene perplasmid, ベペルミノゲンペルプラスミド
It’s only fair to share… 1gctgcttcgc gatgtacggg ccagatatac gcgttgacat tgattattga 51ctagttatta atagtaatca attacggggt cattagttca tagcccatat 101atggagttcc gcgttacata acttacggta aatggcccgc ctggctgacc 151gcccaacgac ccccgcccat tgacgtcaat aatgacgtat gttcccatag 201taacgccaat agggactttc cattgacgtc aatgggtgga gtatttacgg 251taaactgccc acttggcagt acatcaagtg tatcatatgc caagtacgcc 301ccctattgac gtcaatgacg gtaaatggcc cgcctggcat tatgcccagt 351acatgacctt atgggacttt cctacttggc agtacatcta cgtattagtc 401atcgctatta ccatggtgat gcggttttgg cagtacatca atgggcgtgg 451atagcggttt gactcacggg gatttccaag tctccacccc attgacgtca …
BI-882370
It’s only fair to share… BI-882370 XP-102 N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide CAS 1392429-79-6 Chemical Formula: C28H33F2N7O2S Molecular Weight: 569.68 Elemental Analysis: C, 59.03; H, 5.84; F, 6.67; N, 17.21; O, 5.62; S, 5.63 N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide N-(3-{5-[(1-Ethylpiperidin-4-Yl)(Methyl)amino]-3-(Pyrimidin-5-Yl)-1h-Pyrrolo[3,2-B]pyridin-1-Yl}-2,4-Difluorophenyl)propane-1-Sulfonamide N-[3-[5-[(1-ethylpiperidin-4-yl)-methylamino]-3-pyrimidin-5-ylpyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]propane-1-sulfonamide BI 882370 is a highly potent and selective RAF inhibitor that binds to the DFG-out (inactive) conformation of the BRAF kinase. BI …
Aclimostat
It’s only fair to share… Aclimostat CAS: 2082752-83-6 Chemical Formula: C26H42N2O6 Molecular Weight: 478.63 Elemental Analysis: C, 65.25; H, 8.85; N, 5.85; O, 20.06 ZGN-1061; ZGN1061; ZGN 1061; Aclimostat, UNII-X150A3JK8R X150A3JK8R (3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3- methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl 3-[2-(morpholin-4-yl)ethyl]azetidine-1-carboxylate 1-Azetidinecarboxylic acid, 3-[2-(4-morpholinyl)ethyl]-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester 3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1- oxaspiro[2.5]octan-6-yl 3-(2-morpholinoethyl)azetidine-1-carboxylate ZAFGEN, PHASE 2, DIABETES Aclimostat, also known as ZGN-1061, is an anti-diabetic, anti-obesity …
SRT-1720
It’s only fair to share… SRT-1720 diHCl CAY10559 CAS: 1001645-58-4 (di HCl) , 925434-55-5 (free base) 1001645-58-4 (HCl) Chemical Formula: C25H25Cl2N7OS Molecular Weight: 542.483 Elemental Analysis: C, 55.35; H, 4.65; Cl, 13.07; N, 18.07; O, 2.95; S, 5.91 SRT-1720 HCl, SRT-1720 hudrochloride; SRT1720; SRT-1720; SRT 1720; CAY10559; CAY-10559; CAY 10559; SIRT-1933; SIRT 1933; SIRT1933. N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide dihydrochloride Molecular …
Ketorolac
It’s only fair to share… Ketorolac Molecular FormulaC15H13NO3 Average mass255.269 Da 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro- 413572 [Beilstein] 5-(Phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid 5-Benzoyl-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid 74103-06-3 [RN] Ketorolac CAS Registry Number: 74103-06-3 CAS Name: 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid Additional Names: 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid Manufacturers’ Codes: RS-37619 Molecular Formula: C15H13NO3 Molecular Weight: 255.27 Percent Composition: C 70.58%, H 5.13%, N 5.49%, O 18.80% Literature References: Prostaglandin biosynthesis inhibitor. Prepn and separation of …
Cavosonstat (N-91115)
It’s only fair to share… Cavosonstat (N-91115) CAS 1371587-51-7 C16H10ClNO3, 299.71 g/mol UNII-O2Z8Q22ZE4, O2Z8Q22ZE4, NCT02589236; N91115-2CF-05; SNO-6 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid Treatment of Chronic Obstructive Pulmonary Diseases (COPD), AND Cystic fibrosis, Nivalis Therapeutics, phase 2 The product was originated at Nivalis Therapeutics, which was acquired by Alpine Immune Sciences in 2017. In 2018, Alpine announced the sale and transfer of global rights to …